COMPARATIVE EVALUATION OF INFORMATION ON ADVERSE REACTIONS TO MEDICINES

Abstract

Comparative evaluation of information about adverse reactions to medicinal products was carried out on the basis of the research data registered in specialized databases WHO, Russia, Switzerland, USA and the Republic of Kazakhstan. Comparative evaluation of the results of safety monitoring medicines showed that in the Russian Federation the average reporting about adverse reactions below the level recommended by WHO and countries with the most effective system of pharmacovigilance, such as the USA or Switzerland, but higher than in the Republic of Kazakhstan.

Keywords

• лекарственный препарат
• лекарственное средство
• нежелательная реакция
• фармаконадзор
• безопасность
• воз
• россия
• швейцария
• сша
• республика казахстан
• drug
• medicinal products
• safety
• adverse reactions
• pharmacovigilance
• who
• russia
• switzerland
• usa
• republic of kazakhstan